A scientist loads a DNA sample into a gel for laboratory analysis.

Some genetic assays such as this one, at UC San Francisco's Comprehensive Cancer Center, were on perilous legal ground until the Supreme Court Thursday struck down a patent on the sequencing of two genes linked to breast and ovarian cancer.
Justin Sullivan / Getty Images
Copyright © 2018, The Baltimore Sun, a Baltimore Sun Media Group publication | Place an Ad